Sydney, Australia (CU)_ Illuccix, a prostate cancer imaging tool developed by Telix Pharmaceuticals (TLX), has been authorized by the US Food and Drug Administration. The product is a kit for making an…

FDA approves Telix Pharmaceuticals’ prostate cancer treatment

The Post-American World

Rewiring the Mind for Greatness: How Positive Thinking Became a Blueprint for Extraordinary Living

Australian Prime Minister in Singapore amid urgent fuel negotiations!

Babar Azam Silences Critics with Record-Smashing 12,000: Fastest Ever in T20 History

Cyprus’ strategic dilemma in the Eastern Mediterranean

Related Articles

How Disabling a Cellular “Cleanup” Process Could Make Cancer Cells Visible to the Immune System

Nursery Colds: Do They Boost Kids’ Immunity?

Could your weekend drinks be harming your liver?

New Hope for Advanced Prostate Cancer: Could This Hormone Patch Be a Game-Changer?

Could a New Brain Model Built from Artificial Axons Transform the Search for Multiple Sclerosis Treatments?

BRICS expansion: five countries join, another 25 to follow in 2024

Chinese state media lauds India’s achievements under PM Modi!

Security alarm for India: Bangladesh frees Al-Qaeda terror group chief